What is Actavis?

Actavis is a global pharmaceutical company that specializes in the development, manufacturing, and marketing of generic and specialty medications. Founded in 1984, Actavis has grown to become a significant player in the pharmaceutical industry, providing high-quality and cost-effective alternatives to brand-name drugs. The company operates in numerous countries and maintains a diverse portfolio that includes products across various therapeutic areas such as antibiotics, cardiovascular treatments, and central nervous system disorders, among others. Actavis is known for its commitment to innovation in the pharmaceutical field, often focusing on research and development to bring new formulations and delivery methods to market. Additionally, the company emphasizes quality and safety in its manufacturing processes, adhering to stringent regulatory standards set by health authorities worldwide. In 2015, Actavis was acquired by Valeant Pharmaceuticals, and the Actavis name is now integrated into Valeant’s broader portfolio. To learn more about the company and its current operations, individuals may benefit from visiting the official website, which offers updated information on products, services, and contact details.